Tulane University Clinical Translational Unit — New Orleans, Louisiana

Tulane University Clinical Translational Unit is a clinical research site located in New Orleans, Louisiana, United States 70112.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

Tulane University Clinical Translational Unit has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Hemophilia B, COVID-19, Obesity.

Sponsors: Pfizer, National Institute of Allergy and Infectious Diseases (NIAID), Tulane University Health Sciences Center.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tulane University Clinical Translational Unit?

Tulane University Clinical Translational Unit has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tulane University Clinical Translational Unit conducted?

Tulane University Clinical Translational Unit has 3 clinical trials on record, with 1 currently active. Their work covers Hemophilia B, COVID-19, Obesity.

Is Tulane University Clinical Translational Unit accredited by Crixeo Health?

Tulane University Clinical Translational Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tulane University Clinical Translational Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.